Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Blood Grouping Reagents Standardize ABO/Rh Testing on Automated System

By Labmedica staff writers
Posted on 21 Jan 2008
Ready-to-use blood grouping reagents standardize ABO/Rhesus (Rh) blood type testing on an automated microplate system, which is convenient, economic, and efficient.

The new antisera and reagent red blood cells are packaged in ready-to-use vials. More...
No handling or manipulation of the reagents is required other than to transfer them to the appropriate locations on a reagent boat. The color-coded reagents enhance process control by enabling quick visual verification of reagent placement.
The reagents are pre-qualified and standardized for optimal performance, giving them an advantage over the variability of manually prepared reagents. The elimination of dilution studies provides lot-to-lot consistency with none of the troubleshooting issues related to in-house manufactured reagents.

The new automated system is called the Olympus Prausnitz-Kustner (PK) 7200 and was developed by Olympus Diagnostics (Center Valley, PA, USA). The Olympus PK system for blood grouping and phenotyping has been approved by the U.S. Food and Drug Administration (FDA; Rockville, MD, USA).

Olympus Diagnostic Systems provides innovative products that meet the high productivity demands of hospitals, integrated healthcare delivery networks, reference labs, blood banks, and pharmaceutical labs. Olympus offers a broad standardized line of random access chemistry-immuno analyzers, lab automation systems, blood bank analyzers, and reagents.


Related Links:
Olympus Diagnostics
U.S. Food and Drug Administration

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Immunoassay Analyzer
Procise DX
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.